SIRT1/2 Inhibitor IV, Cambinol is a cell-permeable b-naphthol compound that inhibits the NAD-dependent deacetylase activity of SIRT1 and SIRT2 (IC50 = 56 μM and 59 μM, respectively) in a substrate-, but not NAD-, competitive manner. SIRT1/2 Inhibitor IV, Cambinol inhibits SIRT5 deacetylase activity only at much higher concentrations (IC50 >300 μM) and exhibits no inhibition against class I and II HDACs. Cambinol-induced apoptosis in BCL6-expressing Burkitt lymphoma cell lines has been attributed to the hyperacetylation of BCL6 and p53.
Heltweg, B., et al. 2006. Cancer Res. 66, 4368
See how others have used SIRT1/2 Inhibitor IV, Cambinol. Click on the entry to view the PubMed entry .
PMID: # 25424328 Motonishi, S. et al. 2015. J. Am. Soc. Nephrol. 26: 1939-59.
PMID: # 19151729 Van Gool, F. et al. 2009. Nat. Med. 15: 206-210.
PMID: # 18344989 Prozorovski, T. et al. 2008. Nat. Cell Biol. 10: 385-394.
PMID: # 16618762 Heltweg, B. et al. 2006. Cancer Res. 66(8): 4368-4377.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.